Generic Name and Formulations:
C1 esterase inhibitor (recombinant) 2100 IU; per vial; lyophilized pwd for IV inj after reconstitution; preservative-free.
Valeant Pharmaceuticals, Inc
Indications for RUCONEST:
Treatment of acute attacks in adult and adolescent patients with hereditary angioedema (HAE).
Limitations Of use:
Efficacy not established in hereditary angioedema (HAE) patients with laryngeal attacks.
Give by slow IV inj over 5 mins. <84kg: 50 IU/kg. ≥84kg: 4200 IU. Max 4200 IU/dose. May give second dose if attack symptoms persist; max 2 doses/24hrs.
Allergy to rabbits or rabbit-derived products.
Discontinue if hypersensitivity reactions occur. Monitor patients with known risk factors for thrombotic events (eg, indwelling venous catheter, history of thrombosis, atherosclerosis, morbid obesity, immobility). Labor & delivery. Pregnancy (Cat.B). Nursing mothers.
Risk of thrombotic events with concomitant oral contraceptives or certain androgens.
Headache, nausea, diarrhea; thrombotic events, hypersensitivity reactions (may be severe).
Neurology Advisor Articles
- Multiple Sclerosis Guidelines: AAN's Recommendations for Initiating, Switching, Stopping Disease-Modifying Therapy
- Solriamfetol Associated With Improvement in Narcolepsy Types 1 and 2
- Novel Therapy May Improve Symptoms in Early Huntington Disease
- Interaction of Alcohol, Smoking on Multiple Sclerosis Severity
- Are Vaccines Associated With Multiple Sclerosis Relapse?
- The Symbiosis of Headache and Sleep
- Neurosurgery in Parkinson Disease: A Brief History and Look Forward
- Blood Pressure-Dementia Link May Be Affected by Population Characteristics
- The Consequences of Compensation in Autism
- Primary Periodic Paralysis: Advice for Clinicians & Future Directions
- FDA: Lamotrigine Linked to Potentially Life-Threatening Adverse Reaction
- Efficacy of Disease-Modifying Drugs for Multiple Sclerosis May Decrease With Age
- Wearable Sensors May Help Predict On, Off States in Parkinson Disease
- Pain, Psychiatric Comorbidities More Common in Chronic vs Episodic Migraine